Leptin fades as a prime obesity target

After multiple experiments over 15 years, obesity researchers have learned a hard lesson about leptin: It's a lot more complex than they first believed. Once considered a prime target among investigators searching for an effective new therapy, new research has only complicated the picture. Story

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.